Molecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative review

Abstract Sepsis-induced acute kidney injury (S-AKI) is a life-threatening complication of sepsis, marked by dysregulated inflammation, metabolic derangements, and immune dysfunction, driving high mortality. Its multifactorial pathogenesis increasingly implicates DNA methylation-a core epigenetic mec...

Full description

Saved in:
Bibliographic Details
Main Authors: Lili Liu, Saisai Ni, Lianna Zhang, Yingying Chen, Mengqi Xie, Xiaojing Huang
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-025-04179-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849731113174433792
author Lili Liu
Saisai Ni
Lianna Zhang
Yingying Chen
Mengqi Xie
Xiaojing Huang
author_facet Lili Liu
Saisai Ni
Lianna Zhang
Yingying Chen
Mengqi Xie
Xiaojing Huang
author_sort Lili Liu
collection DOAJ
description Abstract Sepsis-induced acute kidney injury (S-AKI) is a life-threatening complication of sepsis, marked by dysregulated inflammation, metabolic derangements, and immune dysfunction, driving high mortality. Its multifactorial pathogenesis increasingly implicates DNA methylation-a core epigenetic mechanism-as a critical disease modulator. This review synthesizes current knowledge of DNA methylation in S-AKI, covering molecular mechanisms, cellular dysfunction, and translational potential. In immune cells, sepsis-induced aberrant DNA methylation promotes hypomethylation of pro-inflammatory genes and hypermethylation of anti-inflammatory loci, exacerbating cytokine storms and immunosuppression. In renal tubular epithelial cells, abnormal methylation disrupts apoptosis, oxidative stress responses, and mitochondrial bioenergetics, impairing repair and accelerating S-AKI progression. Renal vascular endothelial cells exhibit methylation-dependent dysregulation of vasoactive and inflammatory pathways, compromising microvascular homeostasis and renal hemodynamics. DNA methylation signatures offer promise as early S-AKI biomarkers, with cell-type-specific patterns reflecting severity, injury, and prognosis. Targeting DNA methyltransferases with epigenetic modifiers represents a novel therapy, though challenges arise from sepsis’s complex epigenetic landscape-bidirectional methylation changes, histone crosstalk, and context-dependent responses. A key paradox lies in DNA methylation’s dual traits: stability underpinning biomarker reliability and plasticity enabling dynamic inflammatory adaptation, yet introducing therapeutic heterogeneity. Future research should prioritize dissecting cell-specific methylation mechanisms, integrating multi-omics to identify epigenetic subnetworks, and developing real-time monitoring tools for precision diagnosis and tailored interventions. Advancing these frontiers may translate epigenetic insights into transformative strategies to improve outcomes for this devastating condition.
format Article
id doaj-art-4916b32ec60340eb87f39caff9d2429c
institution DOAJ
issn 1471-2369
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj-art-4916b32ec60340eb87f39caff9d2429c2025-08-20T03:08:40ZengBMCBMC Nephrology1471-23692025-05-012611810.1186/s12882-025-04179-zMolecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative reviewLili Liu0Saisai Ni1Lianna Zhang2Yingying Chen3Mengqi Xie4Xiaojing Huang5Department of Emergency MedicineDepartment of Emergency MedicineDepartment of Emergency MedicineDepartment of Emergency MedicineDepartment of Emergency MedicineDepartment of Emergency MedicineAbstract Sepsis-induced acute kidney injury (S-AKI) is a life-threatening complication of sepsis, marked by dysregulated inflammation, metabolic derangements, and immune dysfunction, driving high mortality. Its multifactorial pathogenesis increasingly implicates DNA methylation-a core epigenetic mechanism-as a critical disease modulator. This review synthesizes current knowledge of DNA methylation in S-AKI, covering molecular mechanisms, cellular dysfunction, and translational potential. In immune cells, sepsis-induced aberrant DNA methylation promotes hypomethylation of pro-inflammatory genes and hypermethylation of anti-inflammatory loci, exacerbating cytokine storms and immunosuppression. In renal tubular epithelial cells, abnormal methylation disrupts apoptosis, oxidative stress responses, and mitochondrial bioenergetics, impairing repair and accelerating S-AKI progression. Renal vascular endothelial cells exhibit methylation-dependent dysregulation of vasoactive and inflammatory pathways, compromising microvascular homeostasis and renal hemodynamics. DNA methylation signatures offer promise as early S-AKI biomarkers, with cell-type-specific patterns reflecting severity, injury, and prognosis. Targeting DNA methyltransferases with epigenetic modifiers represents a novel therapy, though challenges arise from sepsis’s complex epigenetic landscape-bidirectional methylation changes, histone crosstalk, and context-dependent responses. A key paradox lies in DNA methylation’s dual traits: stability underpinning biomarker reliability and plasticity enabling dynamic inflammatory adaptation, yet introducing therapeutic heterogeneity. Future research should prioritize dissecting cell-specific methylation mechanisms, integrating multi-omics to identify epigenetic subnetworks, and developing real-time monitoring tools for precision diagnosis and tailored interventions. Advancing these frontiers may translate epigenetic insights into transformative strategies to improve outcomes for this devastating condition.https://doi.org/10.1186/s12882-025-04179-zSepsisAcute kidney injuryDNA methylationEpigeneticsInflammationBiomarkers
spellingShingle Lili Liu
Saisai Ni
Lianna Zhang
Yingying Chen
Mengqi Xie
Xiaojing Huang
Molecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative review
BMC Nephrology
Sepsis
Acute kidney injury
DNA methylation
Epigenetics
Inflammation
Biomarkers
title Molecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative review
title_full Molecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative review
title_fullStr Molecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative review
title_full_unstemmed Molecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative review
title_short Molecular insights and clinical implications of DNA methylation in sepsis-associated acute kidney injury: a narrative review
title_sort molecular insights and clinical implications of dna methylation in sepsis associated acute kidney injury a narrative review
topic Sepsis
Acute kidney injury
DNA methylation
Epigenetics
Inflammation
Biomarkers
url https://doi.org/10.1186/s12882-025-04179-z
work_keys_str_mv AT lililiu molecularinsightsandclinicalimplicationsofdnamethylationinsepsisassociatedacutekidneyinjuryanarrativereview
AT saisaini molecularinsightsandclinicalimplicationsofdnamethylationinsepsisassociatedacutekidneyinjuryanarrativereview
AT liannazhang molecularinsightsandclinicalimplicationsofdnamethylationinsepsisassociatedacutekidneyinjuryanarrativereview
AT yingyingchen molecularinsightsandclinicalimplicationsofdnamethylationinsepsisassociatedacutekidneyinjuryanarrativereview
AT mengqixie molecularinsightsandclinicalimplicationsofdnamethylationinsepsisassociatedacutekidneyinjuryanarrativereview
AT xiaojinghuang molecularinsightsandclinicalimplicationsofdnamethylationinsepsisassociatedacutekidneyinjuryanarrativereview